The medicine shortage reports database includes information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.
You can use this page to search for all medicines in shortage and find information about management actions, including supply of overseas alternative medicines.
Information in this database is based on details reported to us by sponsors. Any additional management actions taken by us will be clearly stated.
How to search
The database defaults to all current medicine shortages. You can also view anticipated and resolved shortages and discontinuations.
To search the database for all shortages and discontinuations for a particular medicine, type the active ingredient or trade (brand) name into the search field. You can then click on the active ingredient name or trade name for more information about the shortage of interest.
You can also download an extract of all shortages and discontinuations.
To view all medicines shortages and discontinuations with a critical shortage impact rating, click on the CRITICAL medicine shortages link below.
Further information
Information about medicine shortages is available at the Medicine Shortages hub
Subscribe to Medicine Shortages updates
You can subscribe to Medicine Shortages Email Alerts or the Medicine Shortages RSS feed for frequently updated information.
This service does not support Internet Explorer 7 and below.
Search Results
Browse CRITICAL shortages and discontinuations
Click here to display ALL medicine shortages and discontinuations
AUST R: 14332
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. Please contact the approval holder for details on supply: Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific - Ph: 02 9503 8100
Updated: 02-01-2024
Updated: 26-08-2026
AUST R: 32486
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 18-02-2026
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)
ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Expected supply: 31 Dec 2027
Availability: Limited Availability
Management action: An overseas-registered product has been approved for supply under section 19A. The approval holder, Link Medical Products Pty Ltd, can be contacted for details on supply on 1800 181 060.
Updated: 14-09-2026
SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule
AUST R: 11060
Expected supply: 30 Nov 2026
Availability: Unavailable
Updated: 16-10-2025
TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack
AUST R: 60673
Expected supply: 31 May 2027
Availability: Unavailable
Management action: An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 13-07-2026
AMIKACIN WOCKHARDT amikacin (as sulfate) 500mg/2mL solution for injection infusion vial
AUST R: 288798
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: Alternative brands are available.
Updated: 16-03-2026
VORICONAZOLE WOCKHARDT voriconazole 200 mg powder for injection vial
AUST R: 267013
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: Alternative brands are available.
Updated: 30-06-2025
ISOPRENALINE MACURE isoprenaline hydrochloride 1 mg/5 mL solution for injection ampoule
AUST R: 370377
Expected supply: Unknown
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 08-01-2026
OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen
AUST R: 170446
Expected supply: 31 Dec 2031
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. An overseas-registered product has been approved for supply under section 19A. The approval holder, Merck Healthcare Pty Ltd, can be contacted for details on supply on 1800 633 463.
Updated: 10-09-2026
PEGASYS peginterferon alfa-2a 135 micrograms/0.5mL injection pre-filled syringe
AUST R: 91836
Expected supply: 31 Jan 2027
Availability: Limited Availability
Management action: This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient. An overseas-registered product has also been approved for supply under Section 19A. The approval holder, Echo Therapeutics Pty Ltd, can be contacted for details on supply on 1300 848 328. The TGA have published a webpage with information about these shortages: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-pegasys-peginterferon-alfa-2a-injection
Updated: 07-08-2026
PEGASYS peginterferon alfa-2a 180 micrograms/0.5mL injection pre-filled syringe
AUST R: 91837
Expected supply: 31 Jan 2027
Availability: Limited Availability
Management action: This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient. An unregistered product has also been approved for supply under Section 19A. The approval holder, Echo Therapeutics Pty Ltd, can be contacted for details on supply on 1300 848 328. The TGA have published a webpage with information about these shortages: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-pegasys-peginterferon-alfa-2a-injection
Updated: 11-09-2026
AUST R: 158452
Expected supply: 31 Jan 2027
Availability: Limited Availability
Management action: The sponsor continues to receive regular supply. Pharmacists experiencing difficulties ordering or obtaining Creon should contact the Viatris Creon Information Line on 1800 806 276 or email Medinfo_anz@viatris.com. For the latest information, see the TGA web statement on the Creon shortage: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-creon-pancreatic-extract-capsules
Updated: 07-10-2026
AUST R: 313833
Expected supply: 31 Jan 2027
Availability: Limited Availability
Management action: The sponsor continues to receive regular supply. Pharmacists experiencing difficulties ordering or obtaining Creon should contact the Viatris Creon Information Line on 1800 806 276 or email Medinfo_anz@viatris.com. For the latest information, see the TGA web statement on the Creon shortage: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-creon-pancreatic-extract-capsules
Updated: 07-10-2026
AUST R: 14328
Expected supply: 31 Aug 2027
Availability: Unavailable
Management action: An overseas-registered product has been approved for supply under section 19A. The approval holder, Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific, can be contacted for details on supply on 02 9503 8100.
Updated: 28-08-2026
APRESOLINE hydralazine hydrochloride 20mg powder for injection ampoule
AUST R: 43190
Expected supply: 31 Mar 2027
Availability: Unavailable
Management action: An overseas-registered product has been approved for supply under section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 04-09-2026
AUST R: 337516
Expected supply: 18 Dec 2026
Availability: Unavailable
Management action: Alternative products are available in other strengths of a different brand.
Updated: 24-04-2026
DBL SULFAMETHOXAZOLE 400 mg and TRIMETHOPRIM 80 mg/5 mL concentrated injection ampoule
AUST R: 16293
Expected supply: 22 Jul 2026
Availability: Available
Updated: 22-07-2026
benzathine benzylpenicillin tetrahydrate
AUST R: 147169
Expected supply: 31 Mar 2027
Availability: Unavailable
Management action: Health professionals are encouraged to consider reserving any remaining Australian-registered Bicillin L-A stock held within their services for paediatric patients. Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. The TGA has published a web statement outlining key information about the shortage which is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-bicillin-l-benzathine-benzylpenicillin-tetrahydrate-prefilled-syringe-injection
Updated: 30-09-2026
AUST R: 82503
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available
Updated: 17-11-2025
PHENYTOIN JUNO (phenytoin sodium) 100mg/ 2mL injection ampoule
AUST R: 117872
Expected supply: Unknown
Availability: Unavailable
Management action: A product in an alternative strength is available.
Updated: 05-06-2026
PHENYTOIN JUNO (phenytoin sodium) 250mg/ 5mL injection ampoule
AUST R: 117865
Expected supply: Unknown
Availability: Unavailable
Management action: An alternative brand is available.
Updated: 11-05-2026
tiagabine hydrochloride monohydrate
GABITRIL tiagabine (as hydrochloride monohydrate) 5mg tablet bottle
AUST R: 120271
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 24-06-2025
tiagabine hydrochloride monohydrate
GABITRIL tiagabine (as hydrochloride monohydrate) 10mg tablet bottle
AUST R: 120272
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 24-06-2025
tiagabine hydrochloride monohydrate
GABITRIL tiagabine (as hydrochloride monohydrate) 15mg tablet bottle
AUST R: 120273
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 24-06-2025
AUST R: 15373
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: The TGA is in consultation with subject matter experts and sponsor to develop a management strategy.
Updated: 08-10-2026
AUST R: 234750
Expected supply: 14 Aug 2026
Availability: Available
Updated: 17-08-2026
AUST R: 394103
Expected supply: 23 Jul 2026
Availability: Available
Updated: 24-07-2026
IMUKIN interferon gamma-1b recombinant human 2 million IU (100 micrograms)/0.5mL injection vial
AUST R: 48404
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Updated: 13-03-2026
TOFRANIL 10 imipramine hydrochloride 10mg tablet blister pack
AUST R: 11064
Expected supply: 28 Jul 2026
Availability: Available
Updated: 28-07-2026
BENPEN benzylpenicillin sodium 1.2g powder for injection vial
AUST R: 10326
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative Australian registered benzylpenicillin sodium injection brands are expected to commence supply. A TGA web statement outlining key information about the discontinuation and availability of alternative brands is available at: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-discontinuation-benpen-benzylpenicillin-sodium-injection-products
Updated: 27-05-2026
AUST R: 10327
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative Australian registered benzylpenicillin sodium injection brands are expected to commence supply. A TGA web statement outlining key information about the discontinuation and availability of alternative brands is available at: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-discontinuation-benpen-benzylpenicillin-sodium-injection-products
Updated: 27-05-2026
BENPEN benzylpenicillin sodium 600mg powder for injection vial
AUST R: 10329
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative Australian registered benzylpenicillin sodium injection brands are expected to commence supply. A TGA web statement outlining key information about the discontinuation and availability of alternative brands is available at: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-discontinuation-benpen-benzylpenicillin-sodium-injection-products
Updated: 27-05-2026
AUST R: 12063
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: An alternative brand is available.
Updated: 24-12-2025
AUST R: 205168
Expected supply: 30 Nov 2026
Availability: Emergency Supply Only
Management action: An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 09-07-2026
AUST R: 100517
Expected supply: 31 Jan 2027
Availability: Limited Availability
Management action: Sponsor is closely controlling the supply.
Updated: 04-06-2026
ENDOXAN cyclophosphamide 2g (as monohydrate) powder for injection vial
AUST R: 82128
Expected supply: 30 Nov 2026
Availability: Limited Availability
Management action: Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals.
An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-cyclophosphamide-and-ifosfamide-injection-shortages
Updated: 23-07-2026
AUST R: 43609
Expected supply: 15 Dec 2026
Availability: Limited Availability
Management action: Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. Alternative unapproved products may be available under the Special Access Scheme. For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme. A TGA web statement is available at: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-cyclophosphamide-and-ifosfamide-injection-shortages.
Updated: 11-08-2026
AUST R: 14032
Expected supply: 30 Jul 2027
Availability: Unavailable
Management action: An overseas registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 17-09-2026
AUST R: 308494
Expected supply: 25 Feb 2027
Availability: Limited Availability
Management action: An overseas-registered product has been approved for supply under Section 19A. The approval holder, Asteri Pharma Pty Ltd, can be contacted for details on supply on 1800 175 659.
Updated: 06-05-2026
VANCOMYCIN BNM vancomycin (as hydrochloride) 250 mg capsule blister pack
AUST R: 375010
Expected supply: 15 Oct 2026
Availability: Available
Updated: 15-10-2026
AUST R: 74894
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: Healthcare professionals to consider alternative treatment options.
Updated: 13-08-2026
ENOXAJECT enoxaparin sodium 20mg/0.2mL solution for injection syringe with safety lock system
AUST R: 423555
Expected supply: 01 Dec 2026
Availability: Unavailable
Management action: Alternative brands are available.
Updated: 25-08-2026
AUST R: 13455
Expected supply: 17 Aug 2026
Availability: Available
Updated: 18-08-2026
AUST R: 24368
Expected supply: 22 Sep 2026
Availability: Available
Management action: The sponsor has advised that this product will continue to be supplied. Further details are available through the following link: www.astrazeneca.com.au/news/media-releases/2026/ASTRAZENECA-TO-EXTEND-PBS-ACCESS-TO-ZOLADEX-goserelin-MONTHLY-3_6mg-IMPLANT.html
Updated: 23-09-2026
PRIORIX-TETRA vaccine 0.5mL powder for injection vial with diluent syringe
AUST R: 107286
Expected supply: 14 Aug 2026
Availability: Available
Updated: 17-08-2026
ENDOXAN cyclophosphamide 1g (as monohydrate) powder for injection vial
AUST R: 82129
Expected supply: 30 Nov 2026
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply and is working to expedite the next shipment. Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals.
An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-cyclophosphamide-and-ifosfamide-injection-shortages
Updated: 29-06-2026
mercaptamine (cysteamine) bitartrate
CYSTAGON mercaptamine (cysteamine) (as bitartrate) 150mg capsule bottle
AUST R: 60452
Expected supply: 31 Jan 2027
Availability: Emergency Supply Only
Management action: An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals.
Updated: 23-09-2026
ENOXAJECT enoxaparin sodium 80mg/0.8mL solution for injection syringe with safety lock system
AUST R: 423558
Expected supply: 31 Oct 2026
Availability: Limited Availability
Management action: Alternative brands are available.
Updated: 02-10-2026
DBL Aciclovir 500mg/20mL Intravenous infusion injection vial
AUST R: 56810
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative brands are available.
Updated: 19-05-2026
DBL Aciclovir 250mg/10mL Intravenous infusion injection vial
AUST R: 56809
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative brands are available.
Updated: 19-05-2026
dantrolene sodium hemiheptahydrate
DANTRIUM dantrolene sodium hemiheptahydrate 20mg powder for injection vial
AUST R: 14435
Expected supply: 25 Aug 2026
Availability: Available
Updated: 25-08-2026
AUST R: 46343
Expected supply: 30 Nov 2026
Availability: Unavailable
Management action: An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 08-09-2026
ENOXAJECT enoxaparin sodium 40mg/0.4mL solution for injection syringe with safety lock system
AUST R: 423556
Expected supply: 31 Oct 2026
Availability: Limited Availability
Management action: Alternative brands are available.
Updated: 02-10-2026
AUST R: 49945
Expected supply: 13 Nov 2026
Availability: Limited Availability
Management action: Alternative brands are available.
Updated: 06-08-2026
Equine antithymocyte immunoglobulin
ATGAM equine antithymocyte immunoglobulin 250mg/5mL injection ampoule
AUST R: 12282
Expected supply: 13 Nov 2026
Availability: Available
Management action: The sponsor is working to expedite the next shipment. An overseas-registered product has been approved for supply under section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals.
Updated: 12-10-2026
AUST R: 43608
Expected supply: 15 Dec 2026
Availability: Unavailable
Management action: Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. Alternative unapproved products may be available under the Special Access Scheme. For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme. A TGA web statement is available at: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-cyclophosphamide-and-ifosfamide-injection-shortages.
Updated: 23-06-2026
AUST R: 176602
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Reduction in supply until supply is exhausted. Patients are advised to consult their health professional to discuss alternative treatment options.
Updated: 01-07-2026
AUST R: 313549
Expected supply: 20 Nov 2026
Availability: Unavailable
Management action: An alternative brand is available.
Updated: 12-10-2026
DOPTELET avatrombopag (as maleate) 20 mg film-coated tablets blister pack
AUST R: 375471
Expected supply: 30 Nov 2026
Availability: Limited Availability
Management action: An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 21-08-2026
AUST R: 125822
Expected supply: 30 Apr 2028
Availability: Available
Management action: Overseas-registered products have been approved for supply under section 19A from 1 December 2026. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 09-10-2026
ENOXAJECT enoxaparin sodium 150mg/1.0mL solution for injection syringe with safety lock system
AUST R: 432818
Expected supply: 01 Nov 2026
Availability: Unavailable
Management action: Alternative brands are available
Updated: 12-10-2026
AUST R: 115049
Expected supply: 08 Jan 2027
Availability: Limited Availability
Management action: The sponsor is working to expedite the next shipment. An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals.
Updated: 21-09-2026
ENOXAJECT enoxaparin sodium 120mg/0.8mL solution for injection syringe with safety lock system
AUST R: 432815
Expected supply: 15 Oct 2026
Availability: Unavailable
Management action: Alternative brands are available.
Updated: 29-09-2026
DBL BLEOMYCIN 15000IU (as sulfate) powder for injection vial
AUST R: 42569
Expected supply: 30 Jun 2028
Availability: Available
Management action: The sponsor is working to expedite the next shipment. An overseas-registered product has been approved for supply under Section 19A from 1 November 2026. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 02-10-2026
AUST R: 47286
Expected supply: 30 Jun 2028
Availability: Available
Management action: The sponsor is closely controlling the supply. An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 02-10-2026
AUST R: 11351
Expected supply: 30 Jun 2028
Availability: Available
Management action: The sponsor is closely controlling the supply. An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 02-10-2026
AUST R: 39954
Expected supply: 30 Jun 2028
Availability: Available
Management action: The sponsor is working to expedite the next shipment. An overseas-registered product has been approved for supply under Section 19A from November 1 2026. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Updated: 14-10-2026
NEUPEDIX alprostadil 500 microgram/1 mL solution for injection ampoule
AUST R: 446011
Expected supply: 30 Nov 2028
Availability: Available
Management action: An alternative brand is available.
Updated: 07-08-2026
FOLOTYN pralatrexate 20 mg/1 mL injection, intravenous infusion vial
AUST R: 192493
Expected supply: 06 Nov 2026
Availability: Unavailable
Management action: An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals.
Updated: 12-10-2026
COLUMVI glofitamab (rch) 2.5 mg/2.5 mL concentrated solution for infusion vial
AUST R: 389650
Expected supply: 10 Sep 2026
Availability: Available
Updated: 11-09-2026
Meningococcal polysaccharide group A
Meningococcal polysaccharide group C
Meningococcal polysaccharide group W135
Meningococcal polysaccharide Group Y
AUST R: 199742
Expected supply: 30 Nov 2026
Availability: Available
Management action: Alternative brands are available. The sponsor has advised that stock will continue to be available for supply under the National Immunisation Program.
Updated: 31-08-2026
THIAMINE STEROP thiamine hydrochloride 100 mg/2 mL solution for injection ampoule
AUST R: 410040
Expected supply: 31 Aug 2026
Availability: Available
Updated: 02-09-2026
ENOXAJECT enoxaparin sodium 60mg/0.6mL solution for injection syringe with safety lock system
AUST R: 423557
Expected supply: 31 Oct 2026
Availability: Limited Availability
Management action: Alternative brands are available.
Updated: 02-10-2026
dexamethasone sodium phosphate
DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 8mg/2mL (as sodium) injection vial
AUST R: 178774
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative brands are available.
Updated: 19-08-2026
AUST R: 47641
Expected supply: 31 May 2027
Availability: Available
Management action: The sponsor is working to expedite the next shipment.
Updated: 21-08-2026
THYROGEN thyrotropin alfa-rch 0.9mg powder for injection vial
AUST R: 79777
Expected supply: 11 Sep 2026
Availability: Available
Updated: 14-09-2026
lapatinib ditosilate monohydrate
TYKERB lapatinib 250mg (as ditosilate monohydrate) tablet bottle
AUST R: 185997
Expected supply: 01 Dec 2026
Availability: Available
Management action: An overseas registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
Updated: 16-10-2026
sodium thiosulfate pentahydrate
AUST R: 276773
Expected supply: 31 Dec 2028
Availability: Available
Management action: An alternative product is available.
Updated: 09-10-2026
Pneumococcal purified capsular polysaccharides
AUST R: 222235
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Other pneumococcal vaccines are available.
Updated: 07-09-2026
AUST R: 18695
Expected supply: 09 Oct 2026
Availability: Available
Updated: 13-10-2026
AUST R: 116832
Expected supply: 31 Dec 2027
Availability: Unavailable
Management action: Healthcare professionals to consider alternative options.
Updated: 06-10-2026
AUST R: 168002
Expected supply: 31 Dec 2027
Availability: Available
Management action: The sponsor is working to expedite the next shipment.
Updated: 09-09-2026
XERMELO telotristat ethyl (as telotristat etiprate) 250 mg film-coated tablet blister pack
AUST R: 291734
Expected supply: 31 Oct 2027
Availability: Available
Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
Updated: 25-09-2026
AUST R: 313131
Expected supply: 06 Nov 2026
Availability: Available
Management action: The sponsor is working to expedite the next shipment. An overseas-registered product has been approved for supply under section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals.
Updated: 25-09-2026
AUST R: 219535
Expected supply: 19 Oct 2026
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment. Healthcare professionals to consider alternative treatment options.
Updated: 15-10-2026
AUST R: 176631
Expected supply: 29 Sep 2026
Availability: Available
Updated: 12-10-2026
AUST R: 235933
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative brands are available.
Updated: 11-10-2026
noradrenaline (norepinephrine) acid tartrate monohydrate
AUST R: 232701
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative brands are available.
Updated: 09-10-2026
AUST R: 313546
Expected supply: 30 Oct 2026
Availability: Limited Availability
Management action: An alternative brand is available.
Updated: 15-10-2026
magnesium sulfate heptahydrate
AUST R: 427032
Expected supply: 13 Dec 2026
Availability: Limited Availability
Management action: The sponsor is working to expedite the next shipment.
Updated: 15-10-2026
dexamethasone sodium phosphate
AUST R: 379531
Expected supply: 20 Nov 2026
Availability: Limited Availability
Management action: The sponsor is working to expedite the next shipment. Alternative brands are available.
Updated: 15-10-2026
{{headingLabels[selectedTab]}}
Sort by: Updated date | Active ingredient | Trade name | Therapeutic class
URL: http://apps.tga.gov.au/prod/MSI/search/